Compare EM & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EM | STXS |
|---|---|---|
| Founded | 2017 | 1990 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 210.0M |
| IPO Year | 2021 | 2004 |
| Metric | EM | STXS |
|---|---|---|
| Price | $1.19 | $2.32 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $1.25 | ★ $4.00 |
| AVG Volume (30 Days) | ★ 715.2K | 392.5K |
| Earning Date | 11-26-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $259,541,587.00 | $30,075,000.00 |
| Revenue This Year | $3.30 | $24.48 |
| Revenue Next Year | $5.26 | $29.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 19.62 |
| 52 Week Low | $0.68 | $1.54 |
| 52 Week High | $1.46 | $3.59 |
| Indicator | EM | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 23.06 | 44.22 |
| Support Level | $1.33 | $2.31 |
| Resistance Level | $1.36 | $2.42 |
| Average True Range (ATR) | 0.05 | 0.09 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 10.00 | 52.42 |
Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.